Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,992 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Feasibility of establishing a multi-center research database using the electronic health record: The PURSUIT network.
Vemulakonda VM, Janzen N, Hittelman AB, Deakyne Davies S, Sevick C, Richardson AC, Schissel J, Dash D, Hintz R, Grider R, Adams P, Buck M, King J, Ewing E, Beltran G, Corbett S, Chiang G. Vemulakonda VM, et al. Among authors: king j. J Pediatr Urol. 2022 Dec;18(6):788.e1-788.e8. doi: 10.1016/j.jpurol.2022.05.004. Epub 2022 May 13. J Pediatr Urol. 2022. PMID: 35644792
Rehabilitation Protocols in Elbow Medial Ulnar Collateral Ligament Injuries: A Systematic Review of Articles Published in the Last 20 Years.
Buchanan TR, Hones KM, Hao KA, Kamarajugadda S, Portnoff B, Wright JO, King JJ, Wright TW, Kim J, Schoch BS, Roach RP, Aibinder WR. Buchanan TR, et al. Among authors: king jj. Sports Health. 2024 May 3:19417381241249125. doi: 10.1177/19417381241249125. Online ahead of print. Sports Health. 2024. PMID: 38702939 Review.
Application of pulsed electric field technology to skin engineering.
Berry-Kilgour C, Wise L, King J, Oey I. Berry-Kilgour C, et al. Among authors: king j. Front Bioeng Biotechnol. 2024 Apr 16;12:1386725. doi: 10.3389/fbioe.2024.1386725. eCollection 2024. Front Bioeng Biotechnol. 2024. PMID: 38689761 Free PMC article. Review.
How Does the Proportion of Never Treatment Influence the Success of Mass Drug Administration Programs for the Elimination of Lymphatic Filariasis?
Kura K, Stolk WA, Basáñez MG, Collyer BS, de Vlas SJ, Diggle PJ, Gass K, Graham M, Hollingsworth TD, King JD, Krentel A, Anderson RM, Coffeng LE. Kura K, et al. Among authors: king jd. Clin Infect Dis. 2024 Apr 25;78(Supplement_2):S93-S100. doi: 10.1093/cid/ciae021. Clin Infect Dis. 2024. PMID: 38662701 Free PMC article.
Reducing the Antigen Prevalence Target Threshold for Stopping and Restarting Mass Drug Administration for Lymphatic Filariasis Elimination: A Model-Based Cost-effectiveness Simulation in Tanzania, India and Haiti.
Antony Oliver MC, Graham M, Gass KM, Medley GF, Clark J, Davis EL, Reimer LJ, King JD, Pouwels KB, Hollingsworth TD. Antony Oliver MC, et al. Among authors: king jd. Clin Infect Dis. 2024 Apr 25;78(Supplement_2):S160-S168. doi: 10.1093/cid/ciae108. Clin Infect Dis. 2024. PMID: 38662697 Free PMC article.
6,992 results